Born with hidden battle: the crucial need for timely syphilis screening in pregnancy
DOI:
https://doi.org/10.66344/jpad.v34i4.2959Keywords:
congenital syphilis, syphilis, vdrlAbstract
We report a case of early congenital syphilis in a 15-day-old male infant, born to parents with untreated syphilis. The infant presented with reddish exfoliating lesions, dry scaly macular lesions, and purulent ear discharge. Laboratory investigations confirmed congenital syphilis. Despite initial diagnosis, the parents' failure to follow up and receive treatment led to this outcome. The infant responded well to intravenous ceftriaxone, and both parents received benzathine penicillin. This case highlights the importance of adherence to recommended testing and treatment protocols to prevent congenital syphilis, which can have severe complications if left untreated. Regular syphilis screening during pregnancy is crucial, with a 98% success rate in preventing transmission to newborns when treated early
References
1. Penner J, Hernstadt H, Burns JE, Randell P, Lyall H. Stop, think SCORTCH: Rethinking the traditional ‘TORCH’ screen in an era of re-emerging syphilis. Arch Dis Child. 2021;106:117-24.
2. Committee on Infectious Diseases, American Academy of Pediatrics. Kimberlin D.W., Barnett E.D., Lynfield R., Sawyer M.H. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics
3. Hawkes S, Matin N, Broutet N, Low N. Effectiveness of interventions to improve screening for syphilis in pregnancy: A systematic review and meta-analysis. Lancet Infect Dis 2011;11:684-91.
4. Hawkes SJ, Gomez GB, Broutet N. Early antenatal care: Does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS One. 2013;8:e56713
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Chandramohan Kudligi, Navya Kalappurakkal , Tejaswini Mukundraj, Nirmitha Sanjeev Kumar, Tejashwini, Ashmika Shetty, Pallavi Chikkadoddi Puttaswamy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
